肝星状细胞通过线粒体代谢转变调控乳酸穿梭影响肝癌干细胞干性的机制研究
项目介绍
AI项目解读
基本信息
- 批准号:81802402
- 项目类别:青年科学基金项目
- 资助金额:20.0万
- 负责人:
- 依托单位:
- 学科分类:H1819.肿瘤生物治疗
- 结题年份:2021
- 批准年份:2018
- 项目状态:已结题
- 起止时间:2019-01-01 至2021-12-31
- 项目参与者:张英才; 李洋; 姚嘉; 郑俊; 陈良; 张杰滨; 陈华欣; 黄一浓;
- 关键词:
项目摘要
Hepatic stellate cells (HSCs), as important interstitial cells in liver cancer microenvironment, play an important role in the malignant process of liver cancer. However, the role of HSCs in hepatocellular carcinoma (HCC) stem cell pool and its regulatory mechanism is unclear. Previous studies by the applicant found that the metabolic shifts of mitochondria play an important role in the malignant transformation of tumors and the self-renewal of stem cells, suggesting that the mitochondrial metabolism mode might affect the cell fates in the tumor microenvironment. Furthermore, we found that after co-culture with the HCC cells, the HSCs were activated with the metabolic pattern change mediated by the AMPK/PGC-1α signaling pathway, meanwhile promoting the stemness of HCC by enhancing the lactate uptake by tumor cells. This study is intended to systematically detect the metabolic phenotype of HSCs in the liver cancer microenvironment on the basis of previous studies. With the use of inhibitors of aerobic glycolysis, we are going to explore the relationship between HSCs metabolic patterns and activation state, as well as the role of metabolites, lactic acid, in promoting stemness of HCC stem cells. Finally, we explored the mechanisms of AMPK / PGC-1α signaling pathway in HSCs mitochondrial metabolic shifts and elucidated the molecular mechanism by which HSC affects the stemness of HCC through lactic-acid shuttle. Taken together, these studies will not only enhance our understandings of the metabolic coupling in the cancer microenvironment, but also provide a theoretical basis for the developing a promising target to reduce the degree of malignancy of liver cancer.
肝星状细胞(HSC)作为肝癌微环境中重要的间质细胞,在肝癌恶性进程中扮演重要角色。然而,HSC对于肝癌干细胞池的作用及调控机制尚不明确。申请人前期研究发现线粒体代谢转变在肿瘤的恶性转化及干细胞的自我更新中扮演重要角色,提示线粒体代谢模式可能影响肿瘤微环境中的细胞命运。进一步,申请人发现与肿瘤共培养后,HSC发生激活,伴随AMPK/PGC-1α信号通路介导的代谢模式转变,并通过增强肿瘤细胞的乳酸摄取,促进肝癌干性。本研究拟在前期基础上,系统检测肝癌微环境中HSC的代谢表型。利用有氧糖酵解抑制剂,研究HSC代谢模式与激活状态的关系,并明确代谢产物乳酸对肝癌干细胞的影响。最后通过激活AMPK/PGC-1α信号,探究在HSC线粒体代谢模式转变中的作用,阐明HSC通过乳酸穿梭影响肝癌干性的分子机制。通过以上研究,不仅增强对肿瘤微环境中代谢偶联的认识,也为研发新靶点降低肝癌恶性程度提供理论依据。
结项摘要
本研究利用肝星状细胞(HSCs)与肝癌细胞体外共培养及体内成瘤模型,深入探究了肝癌纤维化微环境中HSCs与肝癌的相关作用关系,并阐明代谢中间产物乳酸在微环境中的偶联作用。. 本研究发现HSCs在肝癌共培养后发生AMPK/PGC-1α反向调控的糖酵解代谢转变,通过释放代谢中间产物乳酸,促进肝癌的干性、侵袭与转移。进一步研究发现,乳酸通过抑制多囊泡内体的降解,促进与细胞膜融合,促进了肿瘤外泌体的释放。机制研究发现,乳酸通过发挥乳酸化的作用影响外泌体降解释放过程。通过靶向抑制乳酸摄取,能有效抑制肝癌恶性进展。揭示了代谢偶联及乳酸化翻译后修饰在肝癌发生发展中的重要作用。. 鉴于肝癌多发生在肝纤维化背景下,深入探究HSCs的激活机制对于肝癌的发生具有重要意义。利用Nestin-GFP转基因小鼠模型,发现HSCs在肝纤维化中高表达巢蛋白Nestin,机制研究发现Nestin通过抑制TGFβ受体I的泛素化,促进了Smad2/3的磷酸化及HSCs的激活。通过AAV6靶向HSCs中Nestin的表达可有效逆转肝纤维的进展。由此推测肝癌纤维化微环境中激活的HSCs亦表达Nestin,通过抑制HSCs中Nestin的表达可抑制纤维化微环境,进而有效遏制肿瘤恶性进展。. 此外,肿瘤本身warburg效应是肿瘤恶性表型的特征之一。本研究通过分析发现,环状RNA——circFNDC3B通过编码具有功能的多肽circFNDC3B-218aa,影响肿瘤糖酵解转变,进而影响肿瘤的生长。提示除了微环境对肿瘤的相互作用,肿瘤可通过自身机制调控糖代谢变化。. 最后,肝脏缺血再灌注损伤影响了肝癌切除术后肿瘤复发。通过对缺血再灌注损伤模型的研究,发现CD4+T细胞通过表达CD154,促进缺血再灌注损伤。而通过间充质干细胞胞外囊泡(MSC-EVs)的输注,可通过稳定中性粒功能、减轻蛋白质紊乱折叠及影响钙离子信号通路,下调CD154的表达,有效保护了肝缺血再灌注损伤。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer
circFNDC3B编码的新型蛋白质通过调节结肠癌中的Snail抑制肿瘤进展和EMT
- DOI:10.1186/s12943-020-01179-5
- 发表时间:2020-04-02
- 期刊:MOLECULAR CANCER
- 影响因子:37.3
- 作者:Pan, Zihao;Cai, Jianye;Zhang, Lei
- 通讯作者:Zhang, Lei
Heat shock preconditioning mesenchymal stem cells attenuate acute lung injury via reducing NLRP3 inflammasome activation in macrophages.
热休克预处理间充质干细胞通过减少巨噬细胞中NLRP3炎症小体的激活来减轻急性肺损伤
- DOI:10.1186/s13287-021-02328-3
- 发表时间:2021-05-17
- 期刊:Stem cell research & therapy
- 影响因子:7.5
- 作者:Lv H;Yuan X;Zhang J;Lu T;Yao J;Zheng J;Cai J;Xiao J;Chen H;Xie S;Ruan Y;An Y;Sui X;Yi H
- 通讯作者:Yi H
A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial.
一种基于 MSC 的新型 ABO 不相容肝移植免疫诱导策略:I/II 期随机、开放标签、对照试验
- DOI:10.1186/s13287-021-02246-4
- 发表时间:2021-04-16
- 期刊:Stem cell research & therapy
- 影响因子:7.5
- 作者:Zhang Y;Zhang J;Yi H;Zheng J;Cai J;Chen W;Lu T;Chen L;Du C;Liu J;Yao J;Zhao H;Wang G;Fu B;Zhang T;Zhang J;Wang G;Li H;Xiang AP;Chen G;Yi S;Zhang Q;Yang Y
- 通讯作者:Yang Y
Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
靶向巢蛋白肝星状细胞通过促进 TβRI 降解改善肝纤维化
- DOI:10.1016/j.jhep.2020.11.016
- 发表时间:2021-04-15
- 期刊:JOURNAL OF HEPATOLOGY
- 影响因子:25.7
- 作者:Chen, Huaxin;Cai, Jianye;Zhang, Qi
- 通讯作者:Zhang, Qi
Nestin promotes pulmonary fibrosis facilitating recycling of TGF-β receptor I
Nestin 促进肺纤维化,促进 TGF-β 受体 I 的再循环
- DOI:--
- 发表时间:2021
- 期刊:Eur Respir J
- 影响因子:--
- 作者:Wang Jiancheng;Lai Xiaofan;Yao Senyu;Chen Hainan;Cai Jianye;Luo Yulong;Wang Yi;Qiu Yuan;Huang Yinong;Wei Xiaoyue;Wang boyan;Lu Qiying;Guan Yuanjun;Wang Tao;Li Shiyue;Andy Peng Xiang
- 通讯作者:Andy Peng Xiang
共 9 条
- 1
- 2
蔡建业的其他基金
乳酸介导Nestin+肝星状细胞亚群抑制肝纤维化肝部分切除术后再生修复的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
乳酸介导Nestin+肝星状细胞亚群抑制肝纤维化肝部分切除术后再生修复的机制研究
- 批准号:82170631
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目